Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer

Oncology Reports

Volumn 16, Issue 6, 2006, Pages 1189-1196

  Banno, Kouji ^a   Yanokura, Megumi ^a   Susumu, Nobuyuki ^a   Kawaguchi, Makiko ^a   Hirao, Nobumaru ^a   Hirasawa, Akira ^a   Tsukazaki, Katsumi ^a   Aoki, Daisuke ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenomatous polyposis coli; DNA hypermethylation; E cadherin; Endometrial cancer; Human MutL homolog 1; Retinoic acid receptor

Indexed keywords

ARTICLE; DNA METHYLATION; ENDOMETRIUM TUMOR; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MISMATCH REPAIR; POLYMERASE CHAIN REACTION; PROMOTER REGION; TUMOR GENE;

DNA METHYLATION; DNA MISMATCH REPAIR; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS);

EID: 34548711004     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.6.1189     Document Type: Article

References (21)

1. Esteller M, Catasus L, Matias-Guiu X, Mutter GL, Prat J, Baylin SB and Herman JG: hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol 155: 1767-1772, 1999.
2. Kanaya T, Kyo S, Maida Y, Yatabe N, Tanaka M, Nakamura M and Inoue M: Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers. Oncogene 22: 2352-2360, 2003. (Pubitemid 36566790)
3. Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S and Hirohashi S: Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res 58: 3526-3528, 1998. (Pubitemid 28376543)
4. Peiffer SL, Bartsch D, Whelan AJ, Mutch DG, Herzog TJ and Goodfellow PJ: Low frequency of CDKN2 mutation in endometrial carcinomas. Mol Carcinog 13: 210-212, 1995.
5. Nakashima R, Fujita M, Enomoto T, Haba T, Yoshino K, Wada H, Kurachi H, Sasaki M, Wakasa K, Inoue M, Buzard G and Murata Y: Alteration of p16 and p15 genes in human uterine tumours. Br J Cancer 80: 458-467, 1999. (Pubitemid 29213201)
6. Sasaki M, Dharia A, Oh BR, Tanaka Y, Fujimoto S and Dahiya R: Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Cancer Res 61: 97-102, 2001. (Pubitemid 32095706)
7. Widschwendter M, Berger J, Hermann M, Muller HM, Amberger A, Zeschnigk M, Widschwendter A, Abendstein B, Zeimet AG, Daxenbichler G and Marth C: Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J Natl Cancer Inst 92: 826-832, 2000. (Pubitemid 30368039)
8. Ueki T, Toyota M, Skinner H, Walter KM, Yeo CJ, Issa JP, Hruban RH and Goggins M: Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. Cancer Res 61: 8540-8546, 2001. (Pubitemid 33131137)
9. Susumu N, Aoki D, Noda T, Nagashima Y, Hirao T, Tamada Y, Banno K, Suzuki A, Suzuki N, Tsuda H, Inazawa J and Nozawa S: Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers. Int J Gynecol Cancer 15: 70-80, 2005. (Pubitemid 40194336)
10. Banno K, Susumu N, Hirao T, Yanokura M, Hirasawa A, Aoki D, Udagawa Y, Sugano K and Nozawa S: Two Japanese kindreds occurring endometrial cancer meeting new clinical criteria for hereditary non-polyposis colorectal cancer (HNPCC), Amsterdam Criteria II. J Obstet Gynaecol Res 30: 287-292, 2004. (Pubitemid 39108442)
11. Wu ZY, Zhan WH, Li JH, He YL, Wang JP, Lan P, Peng JS and Cai SR: Expression of E-cadherin in gastric carcinoma and its correlation with lymph node micrometastasis. World J Gastroenterol 11: 3139-3143, 2005. (Pubitemid 40790678)
12. Oue N, Oshimo Y, Nakayama H, Ito R, Yoshida K, Matsusaki K and Yasui W: DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype. Cancer Sci 94: 901-905, 2003. (Pubitemid 37406973)
13. Hong SH, Kim HG, Chung WB, Kim EY, Lee JY, Yoon SM, Kwon JG, Sohn YK, Kwak EK and Kim JW: DNA hypermethylation of tumor-related genes in gastric carcinoma. J Korean Med Sci 20: 236-241, 2005.
14. Chen G, Liu T and He J: Status of methylation of promoter of mismatch repair gene hMLH1 in lung cancer. Chung Hua Chung Liu Tsa Chih 22: 493-495, 2000.
15. Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y and Motoyama T: Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci 94: 589-592, 2003. (Pubitemid 36975012)
16. Baldinu P, Cossu A, Manca A, Satta MP, Pisano M, Casula M, Dessole S, Pintus A, Tanda F and Palmieri G: Microsatellite instability and mutation analysis of candidate genes in unselected Sardinian patients with endometrial carcinoma. Cancer 94: 3157-3168, 2002. (Pubitemid 34670499)
17. Kowalski LD, Mutch DG, Herzog TJ, Rader JS and Goodfellow PJ: Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers. Genes Chromosomes Cancer 18: 219-227, 1997. (Pubitemid 27120341)
18. Moreno-Bueno G, Hardisson D, Sanchez C, Sarrio D, Cassia R, Garcia-Rostan G, Prat J, Guo M, Herman JG, Matias-Guiu X, Esteller M and Palacios J: Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Oncogene 21: 7981-7990, 2002. (Pubitemid 35430609)
19. Saito T, Nishimura M, Yamasaki H and Kudo R: Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma. Cancer 97: 1002-1009, 2003. (Pubitemid 36173151)
20. Wong YF, Chung TK, Cheung TH, Nobori T, Yu AL, Batova A, Lai KW and Chang AM: Methylation of p16INK4A in primary gynecologic malignancy. Cancer Lett 136: 231-235, 1999. (Pubitemid 29164397)
21. Yanokura M, Banno K, Susumi N, Kwaguchi M, Kuwabara Y, Tsukazaki K and Aoki D: Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients. Anticancer Res 26: 851-856, 2006. Technology